Abstract: Rate-corrected QT interval (QTc) prolongation has been suggested as a biomarker for the risk of drug-induced torsades de pointes, and is therefore monitored during clinical trials for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback